Description
HETEROCYCLIC COMPOUNDS
HETEROCYCLIC COMPOUNDS
Subclass | Title |
---|---|
201/00 | Preparation, separation, purification, or stabilisation of unsubstituted lactams |
201/02 | Preparation, separation, purification, or stabilisation of unsubstituted lactams Preparation of lactams |
201/04 | Preparation, separation, purification, or stabilisation of unsubstituted lactams Preparation of lactams from or via oximes by Beckmann rearrangement |
201/06 | Preparation, separation, purification, or stabilisation of unsubstituted lactams Preparation of lactams from or via oximes by Beckmann rearrangement from ketones by simultaneous oxime formation and rearrangement |
201/08 | Preparation, separation, purification, or stabilisation of unsubstituted lactams Preparation of lactams from carboxylic acids or derivatives thereof, e.g. hydroxy carboxylic acids, lactones, nitriles |
201/10 | Preparation, separation, purification, or stabilisation of unsubstituted lactams Preparation of lactams from cycloaliphatic compounds by simultaneous nitrosylation and rearrangement |
201/12 | Preparation, separation, purification, or stabilisation of unsubstituted lactams Preparation of lactams by depolymerising polyamides |
201/14 | Preparation, separation, purification, or stabilisation of unsubstituted lactams Preparation of salts or adducts of lactams |
201/16 | Preparation, separation, purification, or stabilisation of unsubstituted lactams Separation or purification |
201/18 | Preparation, separation, purification, or stabilisation of unsubstituted lactams Stabilisation |
203/00 | Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom |
203/02 | Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom Preparation by ring-closure |
203/04 | Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings |
203/06 | Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members |
203/08 | Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring nitrogen atom |
203/10 | Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring nitrogen atom Radicals substituted by singly bound oxygen atoms |
203/12 | Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring nitrogen atom Radicals substituted by nitrogen atoms not forming part of a nitro radical |
203/14 | Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring nitrogen atom with carbocyclic rings directly attached to the ring nitrogen atom |
203/16 | Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with acylated ring nitrogen atoms |
203/18 | Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with acylated ring nitrogen atoms by carboxylic acids, or by sulfur or nitrogen analogues thereof |
Publication # | Title | Filing Date | Pub Date | Patent Owner |
---|---|---|---|---|
2025/0114,305 | LIPIDIC COMPOUNDS, AND USES THEREOF | Jan 16, 23 | Apr 10, 25 | Not available |
2025/0114,326 | POLAR MARINE-DERIVED MACROCYCLIC LACTAM COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF | Nov 25, 22 | Apr 10, 25 | RENJI HOSPITAL, SCHOOL OF MEDICINE, SHANGHAI JIAO TONG UNIVERSITY |
2025/0114,327 | COMPOSITION COMPRISING TETRACYCLIC COMPOUND | May 07, 24 | Apr 10, 25 | Chugai Seiyaku Kabushiki Kaisha |
2025/0114,338 | TETRAHYDRO-PYRIDO[3,4-b]INDOLE ESTROGEN RECEPTOR MODULATORS AND USES THEREOF | Dec 18, 24 | Apr 10, 25 | Genentech, Inc. |
2025/0114,345 | COMPOUNDS AND COMPOSITIONS AS CBP/P300 DEGRADERS AND USES THEREOF | Aug 30, 24 | Apr 10, 25 | Not available |
2025/0114,356 | INDAZOLE BASED COMPOUNDS AND ASSOCIATED METHODS OF USE | Aug 05, 24 | Apr 10, 25 | Not available |
2025/0114,357 | BIFUNCTIONAL PROTAC AND MOLECULAR GLUE COMPOUNDS AND METHODS OF USE THEREOF | Oct 09, 24 | Apr 10, 25 | Not available |
2025/0114,361 | PYRAZOLOPYRIMIDINE COMPOUND AND PHARMACEUTICAL USE THEREOF | Aug 28, 23 | Apr 10, 25 | Not available |
2025/0114,369 | COMPOUNDS AND METHODS FOR TREATMENT OF VIRAL INFECTIONS | Sep 13, 24 | Apr 10, 25 | Not available |
2025/0114,374 | BCL-2 INHIBITORS | Dec 19, 22 | Apr 10, 25 | Not available |
2025/0114,380 | SMALL MOLECULE CD38 INHIBITORS AND METHODS OF USING SAME | Jun 10, 24 | Apr 10, 25 | President and Fellows of Harvard College; Mayo Foundation for Medical Education and Research; |
2025/0114,428 | DIPEPTIDOMIMETICS AS INHIBITORS OF HUMAN IMMUNOPROTEASOMES | May 03, 24 | Apr 10, 25 | Not available |
2025/0114,647 | ANTIBODY-DRUG CONJUGATES COMPRISING SUBSTITUTED BENZO[e]PYRROLO[1,2-a][1,4]DIAZEPINES | Dec 12, 24 | Apr 10, 25 | Daiichi Sankyo Company Limited |
2025/0115,545 | TERPENE-CONTAINING LIPIDOIDS FOR GENE DELIVERY | Jan 20, 23 | Apr 10, 25 | Not available |
2025/0115,546 | LINKERS FOR ANTIBODY DRUG CONJUGATES | Aug 20, 24 | Apr 10, 25 | Not available |
2025/0115,548 | COMPOUNDS AS SOLUBLE EPOXIDE HYDROLASE INHIBITORS | Oct 14, 24 | Apr 10, 25 | Not available |
2025/0115,551 | SYNTHESIS OF RAS INHIBITORS | Oct 02, 24 | Apr 10, 25 | Not available |
2025/0115,552 | CRYSTALLINE HYDROCHLORIDE SALTS OF N-ETHYL-2-(5-FLUORO-1H-INDOL-3-YL)-N-METHYLETHAN-1-AMINE | Oct 29, 24 | Apr 10, 25 | Gilgamesh Pharmaceuticals, Inc. |
2025/0115,553 | AN EFFICIENT NEW PROCESS FOR SYNTHESIS OF 2-AMINO-5-CHLORO-N-,3-DIMETHYLBENZAMIDE | Oct 10, 23 | Apr 10, 25 | Not available |
2025/0115,554 | NITROGEN-CONTAINING COMPOUND, ELECTRONIC ELEMENT AND ELECTRONIC DEVICE | May 15, 23 | Apr 10, 25 | Not available |
Upgrade to the Professional Level to view Top Owners for this Class.Learn More |
---|